Showing results (291-300 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|October 16, 2008
Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT studySusan G Kornstein, James H Kocsis, Saeeduddin Ahmed, et al.International Clinical Psychopharmacology|June 10, 2017
Long-term function and psychosocial outcomes with venlafaxine extended release 75-225 mg/day versus placebo in the PREVENT studyKoichiro Watanabe, Michael E Thase, Toshiaki Kikuchi, et al.International Clinical Psychopharmacology|August 11, 2018
The use of (newer) antipsychotics in bipolar inpatients over a 17-year observation periodJulia Dehning, Heinz Grunze, Michaela Walpoth-Niederwanger, et al.International Clinical Psychopharmacology|May 26, 2017
Trends and factors associated with antipsychotic use among elderly patients with dementia in Taiwan from 2005 to 2013: a population-based studyYu-Wen Chiu, Chih-Wan Huang, Pei-Jung Chen, et al.International Clinical Psychopharmacology|May 9, 2018
Pharmacological treatment of sexual offenders in German outpatient treatment centersDaniel Turner, Priscilla Gregório Hertz, Julia Sauter, et al.International Clinical Psychopharmacology|June 5, 2018
Effects of anxiety on suicidal ideation: exploratory analysis of a paroxetine versus bupropion randomized trialMichelle S Parris, Julia E Marver, Sadia R Chaudhury, et al.International Clinical Psychopharmacology|January 15, 2010
Patient characteristics and predictors of sleep medication useSiri Omvik, Ståle Pallesen, Bjørn Bjorvatn, et al.International Clinical Psychopharmacology|July 11, 2017
Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studiesWillie Earley, Suresh Durgam, Kaifeng Lu, et al.International Clinical Psychopharmacology|January 12, 2010
Relationship of residual mood and panic-agoraphobic spectrum phenomenology to quality of life and functional impairment in patients with major depressionAntonella Benvenuti, Paola Rucci, Simona Calugi, et al.International Clinical Psychopharmacology|January 13, 2010
The effects of psychopathology on subjective experience of side effects of antipsychotics in patients with schizophreniaSamuel Suk-Hyun Hwang, Dong Chung Jung, Yong Min Ahn, et al.Pageof 212